154 related articles for article (PubMed ID: 9280323)
1. Anaphylatoxins in fresh-frozen plasma.
Sonntag J; Stiller B; Walka MM; Maier RF
Transfusion; 1997 Aug; 37(8):798-803. PubMed ID: 9280323
[TBL] [Abstract][Full Text] [Related]
2. Complement activation during plasma production depends on the apheresis technique.
Sonntag J; Emeis M; Vornwald A; Strauss E; Maier RF
Transfus Med; 1998 Sep; 8(3):205-8. PubMed ID: 9800292
[TBL] [Abstract][Full Text] [Related]
3. Anaphylatoxin and terminal complement complexes in red cell salvage.
Bengtsson A; Lisander B
Acta Anaesthesiol Scand; 1990 Jul; 34(5):339-41. PubMed ID: 2389647
[TBL] [Abstract][Full Text] [Related]
4. Anaphylatoxin generation and distribution during in vitro LDL apheresis.
Parusel M; Kadar JG; Borberg H
Infusionsther Transfusionsmed; 1992 Oct; 19(5):245-8. PubMed ID: 1288769
[TBL] [Abstract][Full Text] [Related]
5. Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters.
Geiger TL; Perrotta PL; Davenport R; Baril L; Snyder EL
Transfusion; 1997; 37(11-12):1156-62. PubMed ID: 9426639
[TBL] [Abstract][Full Text] [Related]
6. [Determination of C3a and C5a in hemapheresis procedures].
Schooneman F; Marchand M; Vigneron C; Streiff F
Ann Med Interne (Paris); 1990; 141(7):597-9. PubMed ID: 2085237
[TBL] [Abstract][Full Text] [Related]
7. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis.
Roxvall LI; Bengtson LA; Heideman JM
Arch Surg; 1990 Jul; 125(7):918-21. PubMed ID: 2369318
[TBL] [Abstract][Full Text] [Related]
8. Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration.
Arnestad JP; Hyllner M; Bengtson JP; Tylman M; Mollnes TE; Bengtsson A
Acta Anaesthesiol Scand; 1998 Aug; 42(7):811-5. PubMed ID: 9698958
[TBL] [Abstract][Full Text] [Related]
9. Altered concentrations of terminal complement complexes, anaphylatoxins, and leukotrienes in the coronary sinus during cardiopulmonary bypass.
Bengtson A; Millocco I; Heideman M; Berggren H
J Cardiothorac Anesth; 1989 Jun; 3(3):305-10. PubMed ID: 2520655
[TBL] [Abstract][Full Text] [Related]
10. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
Fujino S; Sakurabayashi I
Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
[No Abstract] [Full Text] [Related]
11. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
12. Complement activation during storage of whole blood, red cells, plasma, and buffy coat.
Hyllner M; Arnestad JP; Bengtson JP; Rydberg L; Bengtsson A
Transfusion; 1997 Mar; 37(3):264-8. PubMed ID: 9122898
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in neonatal disease.
Zilow EP
Eur J Pediatr; 1993 May; 152(5):459-60. PubMed ID: 8319722
[No Abstract] [Full Text] [Related]
14. Measurement of anaphylatoxin activity during surgery.
Harada T; Sakagami M; Sano M; Matsunaga T
Acta Otolaryngol Suppl; 1993; 501():88-91. PubMed ID: 8447233
[TBL] [Abstract][Full Text] [Related]
15. Anaphylatoxins in preterm and term labor.
Soto E; Romero R; Richani K; Espinoza J; Nien JK; Chaiworapongsa T; Santolaya-Forgas J; Edwin SS; Mazor M
J Perinat Med; 2005; 33(4):306-13. PubMed ID: 16207115
[TBL] [Abstract][Full Text] [Related]
16. Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress.
Enskog A; Bengtsson A; Bengtson JP; Heideman M; Andreasson S; Larsson L
Eur J Pediatr; 1996 Jan; 155(1):41-5. PubMed ID: 8750809
[TBL] [Abstract][Full Text] [Related]
17. Assessment of complement activation during membrane-based plasmapheresis procedures.
Burnouf T; Eber M; Kientz D; Cazenave JP; Burkhardt T
J Clin Apher; 2004; 19(3):142-7. PubMed ID: 15493055
[TBL] [Abstract][Full Text] [Related]
18. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic treatment and complement activation.
Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
[TBL] [Abstract][Full Text] [Related]
20. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
